Maven Securities’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-200,000
Closed -$3.33M 515
2023
Q1
$3.33M Buy
+200,000
New +$3.33M 0.07% 42